Precigen (PGEN) Current Deferred Revenue (2016 - 2025)

Historic Current Deferred Revenue for Precigen (PGEN) over the last 14 years, with Q3 2025 value amounting to $575000.0.

  • Precigen's Current Deferred Revenue fell 7642.48% to $575000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $575000.0, marking a year-over-year decrease of 7642.48%. This contributed to the annual value of $2.5 million for FY2024, which is 842.29% up from last year.
  • Latest data reveals that Precigen reported Current Deferred Revenue of $575000.0 as of Q3 2025, which was down 7642.48% from $2.2 million recorded in Q2 2025.
  • In the past 5 years, Precigen's Current Deferred Revenue registered a high of $26.9 million during Q1 2021, and its lowest value of $15000.0 during Q2 2023.
  • Over the past 5 years, Precigen's median Current Deferred Revenue value was $2.3 million (recorded in 2023), while the average stood at $9.3 million.
  • Per our database at Business Quant, Precigen's Current Deferred Revenue crashed by 9993.53% in 2023 and then skyrocketed by 1454000.0% in 2024.
  • Quarter analysis of 5 years shows Precigen's Current Deferred Revenue stood at $24.5 million in 2021, then plummeted by 92.48% to $1.8 million in 2022, then rose by 26.26% to $2.3 million in 2023, then increased by 8.42% to $2.5 million in 2024, then plummeted by 77.21% to $575000.0 in 2025.
  • Its Current Deferred Revenue stands at $575000.0 for Q3 2025, versus $2.2 million for Q2 2025 and $2.4 million for Q1 2025.